---
title: Routine Spironolactone in Acute Myocardial Infarction
date: '2024-11-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39555814/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20241119173555&v=2.18.0.post9+e462414
source: N Engl J Med
description: 'CONCLUSIONS: Among patients with myocardial infarction, spironolactone
  did not reduce the incidence of death from cardiovascular causes or new or worsening
  heart failure or the incidence of a composite of death from cardiovascular causes,
  myocardial infarction, stroke, or new or worsening heart failure. (Funded by the
  Canadian Institutes of Health Research and others; CLEAR ClinicalTrials.gov number,
  ...'
disable_comments: true
---
CONCLUSIONS: Among patients with myocardial infarction, spironolactone did not reduce the incidence of death from cardiovascular causes or new or worsening heart failure or the incidence of a composite of death from cardiovascular causes, myocardial infarction, stroke, or new or worsening heart failure. (Funded by the Canadian Institutes of Health Research and others; CLEAR ClinicalTrials.gov number, ...